|
Harvard Clinical Research Institute Initiates Comparative Effectiveness Study …
Genetic Engineering News Tiotropium) Study, the purpose of which is to investigate whether Black patients with asthma are more likely to experience adverse outcomes as a result of long-acting beta-agonist (LABA) therapy. The BELT study was funded by a grant from the Agency for … |
View full post on asthma – Google News